[Treatment of asthma with salmeterol--a new prolonged-action inhalatory beta 2 agonist].
Dahl
R
R
Arhus Kommunehospital, lungemedicinsk afdeling.
Pedersen
B
B
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics; D001249:Asthma / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D006801:Humans; D000068299:Salmeterol Xinafoate
D000318:Adrenergic beta-Agonists; D003692:Delayed-Action Preparations; D000068299:Salmeterol Xinafoate; D000420:Albuterol
Asthmabehandling med salmeterol--en ny langtidsvirkende inhaleret beta-2-agonist.